Immediate Impact
5 from Science/Nature 60 standout
Citing Papers
Empagliflozin in Patients with Chronic Kidney Disease
2022 Standout
Critical Reanalysis of the Mechanisms Underlying the Cardiorenal Benefits of SGLT2 Inhibitors and Reaffirmation of the Nutrient Deprivation Signaling/Autophagy Hypothesis
2022 Standout
Works of Peter Ivanovich being referenced
Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes
2010
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
2009 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Peter Ivanovich | 1476 | 1695 | 306 | 605 | 75 | 3.3k | |
| Marsha Wolfson | 2345 | 1828 | 386 | 588 | 59 | 4.1k | |
| Naomi Clyne | 2051 | 1410 | 231 | 472 | 82 | 3.4k | |
| Lawrence P. McMahon | 1541 | 850 | 344 | 371 | 98 | 3.5k | |
| Daniel W. Coyne | 2324 | 1733 | 647 | 1070 | 119 | 5.0k | |
| Lucia Del Vecchio | 2334 | 1112 | 564 | 380 | 171 | 3.8k | |
| Steven Fishbane | 1028 | 1421 | 280 | 741 | 70 | 2.4k | |
| Jay B. Wish | 1453 | 1136 | 481 | 565 | 89 | 2.9k | |
| G Mecca | 1364 | 863 | 699 | 320 | 59 | 3.3k | |
| Joseph W. Eschbach | 1408 | 2906 | 255 | 950 | 45 | 3.7k | |
| John K. Maesaka | 1303 | 933 | 786 | 560 | 79 | 3.4k |
All Works
Loading papers...